Caplin Point Laboratories reported strong Q4 FY26 results

Caplin Point Laboratories reported strong Q4 FY26 results today, with net profit rising to ₹170.11 crore (up 3.8% QoQ, 19.3% YoY) and revenue touching ₹600.16 crore (up 10.6% QoQ, 19.5% YoY). The stock is trading around ₹2,689 on NSE/BSE, near its 52-week high of ₹2,700, showing a bullish trend. 📊 Caplin Point Q4 FY26 Results Revenue: ₹600.16 crore (↑10.57% QoQ, ↑19.45% YoY) Operating Profit: ₹185.44 crore (↑8.82% QoQ, ↑22.79% YoY) Net Profit (PAT): ₹170.11 crore (↑3.8% QoQ, ↑19.32% YoY) Operating Margin: 30.9% Diluted EPS: ₹22.31 (↑3.72% QoQ, ↑19.29% YoY) Trend: Strong bullish momentum in both short-term and long-term technicals 💹 Share Price Performance (Sep 1, 2026) Current Price: ₹2,689 (NSE/BSE) Day Range: ₹2,521.40 – ₹2,752.55 52-Week Range: ₹1,502.45 – ₹2,700.00 YTD Return: +49.23% 1-Year Return: +27.5% Volatility (Beta): 1.13 (medium volatility) Dividend Yield: 0.32% (lower than industry average)